ROIV short interest
Roivant Sciences Ltd. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 39,296,630 |
|---|---|
| Change vs prior report | 3,115,082 (+8.6%) |
| Change over six months | +57.9% |
| Days to cover | 4.43 (sector: 3.78) |
| Average daily volume | 8,877,408 |
| Rank in Healthcare | #469 of 922 by days to cover |
ROIV short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 39,296,630 | +8.6% | 4.43 | 8,877,408 |
| 2026-09-15 | 36,181,548 | +7.9% | 4.13 | 8,751,820 |
| 2026-08-31 | 33,522,300 | +9.5% | 3.83 | 8,757,588 |
| 2026-08-14 | 30,601,726 | -13.2% | 5.01 | 6,103,989 |
| 2026-07-31 | 35,233,818 | -4.0% | 7.99 | 4,407,819 |
| 2026-07-15 | 36,695,558 | +10.5% | 7.65 | 4,798,919 |
| 2026-06-30 | 33,212,917 | -0.1% | 4.27 | 7,782,780 |
| 2026-06-15 | 33,244,439 | -8.2% | 7.52 | 4,423,546 |
| 2026-05-29 | 36,233,835 | +32.4% | 4.14 | 8,748,838 |
| 2026-05-15 | 27,377,524 | +1.2% | 5.69 | 4,807,466 |
| 2026-04-30 | 27,055,375 | +10.6% | 4.83 | 5,595,903 |
| 2026-04-15 | 24,470,022 | -1.7% | 5.79 | 4,229,831 |
| 2026-03-31 | 24,884,496 | +6.4% | 4.30 | 5,793,424 |
| 2026-03-13 | 23,387,772 | -0.3% | 3.63 | 6,440,939 |
| 2026-02-27 | 23,457,731 | +5.3% | 5.10 | 4,598,282 |
| 2026-02-13 | 22,266,323 | -4.4% | 2.43 | 9,170,829 |
| 2026-01-30 | 23,288,019 | -5.1% | 5.08 | 4,582,244 |
| 2026-01-15 | 24,529,353 | +25.3% | 3.67 | 6,681,612 |
| 2025-12-31 | 19,579,958 | +11.8% | 2.46 | 7,948,165 |
| 2025-12-15 | 17,520,355 | -16.2% | 2.21 | 7,915,441 |
| 2025-11-28 | 20,914,523 | -9.3% | 3.67 | 5,699,020 |
| 2025-11-14 | 23,049,893 | -6.0% | 2.41 | 9,547,574 |
| 2025-10-31 | 24,528,207 | -2.9% | 2.78 | 8,812,288 |
| 2025-10-15 | 25,271,869 | -9.6% | 3.79 | 6,660,670 |
| 2025-09-30 | 27,966,982 | -22.8% | 2.87 | 9,744,740 |
import finzdata as yf
yf.Ticker("ROIV").short_interest # every report since 2017
yf.Client().short_interest(["ROIV"], start="2018-01-01")Healthcare short interest · ROIV price history · Who owns ROIV · All short interest